Vol. 12 No. 2 (2024)
Published:
2024-08-13
Articles
-
Abstract views: 398https://doi.org/10.61096/ijphr.v12.iss2.2024.80-83
-
Abstract views: 300https://doi.org/10.61096/ijphr.v12.iss2.2024.159-171
-
Abstract views: 238https://doi.org/10.61096/ijphr.v12.iss2.2024.149-158
-
Abstract views: 495https://doi.org/10.61096/ijphr.v12.iss2.2024.144-148
-
Abstract views: 664https://doi.org/10.61096/ijphr.v12.iss2.2024.130-143
-
Formulation Development And In Vitro Characterisation Of Deflazacort Extended Release Matrix TabletsAbstract views: 483https://doi.org/10.61096/ijphr.v12.iss2.2024.118-129
-
Abstract views: 282https://doi.org/10.61096/ijphr.v12.iss2.2024.107-117
-
Abstract views: 215https://doi.org/10.61096/ijphr.v12.iss2.2024.96-106
-
Abstract views: 285https://doi.org/10.61096/ijphr.v12.iss2.2024.84-95
-
Formulation Development And In Vitro Characterisation Of Deflazacort Extended Release Matrix TabletsAbstract views: 297https://doi.org/10.61096/ijphr.v12.iss2.2024.73-79
-
Abstract views: 237https://doi.org/10.61096/ijphr.v12.iss2.2024.64-72
-
Abstract views: 511https://doi.org/10.61096/ijphr.v12.iss2.2024.55-63
-
Abstract views: 568https://doi.org/10.61096/ijphr.v12.iss2.2024.35-45
-
Abstract views: 419https://doi.org/10.61096/ijphr.v12.iss2.2024.26-34
